Neuralink Brain Chip Explained: What the Hardware Actually Does Inside the Human Brain
Most people focus on the headlines. Engineers focus on the hardware. Here’s how Neuralink’s brain-computer interface works, from ultra-thin electrodes and custom chips to wireless communication and real-time neural signal processing.
Table of Contents
Let me start somewhere in the middle, because that’s where the real story is.
Roughly 85% of Noland Arbaugh’s electrode threads had pulled back from his brain tissue within three months of his implant going in. Not a small number. Most of them. And yet — the cursor still worked. Neuralink disclosed this publicly, patched it with a smarter decode algorithm, and moved on. That one detail tells you more about what this tech actually is than any launch event video ever could.
Now let me back up.
January 28, 2024. Arbaugh — 29 years old, quadriplegic, hadn’t moved his hands in eight years after a diving accident — sat in front of a screen and moved a cursor. With his thoughts. No hands. No joystick. Nothing. Just intent, picked up by a chip the size of a coin beneath his skull, fired wirelessly to a receiver nearby.
That moment wasn’t magic. It was hardware. This is the Neuralink brain chip explained from the inside — not the press release version, but the actual hardware version.
I’ve been in PCB and electronics manufacturing for over 20 years. I’ve worked on complex board-level systems with some tight specs. And I’ll say this plainly: what Neuralink pulled off at the chip and system level is one of the harder things I’ve seen done. Not because the concept is new — BCIs have been around for decades. Because the physics is brutal and the substrate, a living human brain, actively fights back.
If you want to know what’s actually happening inside that skull when the chip runs — keep reading.
The Big Picture: What Is a BCI, Really?
Here’s what most explainers get wrong right out of the gate. A brain-computer interface (BCI) doesn’t “read minds.” It reads voltage.
Your neurons talk by firing tiny electrochemical spikes called action potentials. That’s it. A BCI’s job is to catch those spikes, figure out what they mean, and turn them into a digital command fast enough to feel real. No thoughts. No feelings. Just electrical events, detected and decoded.
I think people hear “brain chip” and picture something like a USB drive plugged into a skull. It’s nothing like that. It’s a signal-capture problem operating at tolerances that would make most fab engineers sweat — in a substrate that moves, bleeds, and tries to wall off anything it doesn’t recognize as self.
Neuralink’s system — branded Telepathy for its first consumer use — ranks among the highest channel-count intracortical BCI systems deployed in humans to date. Not the only player (Blackrock Neurotech and Synchron are both operating clinically), but by raw electrode count, it’s near the top.
Three hardware pieces run this:
- The N1 Implant — the actual chip that lives inside your skull, handles all the signal capture and processing, and is the piece nobody adequately explains
- The R1 Robot
- The N1 User App and external receiver, which is the wireless decode layer that turns compressed neural data into something a laptop can act on
Each one is its own hard engineering problem. Don’t let the clean product photos fool you.
The Neuralink N1 Implant: What’s Actually Inside Your Skull
Size and Placement
Let’s start with a number most coverage buries: 23mm × 8mm. That’s the N1 Implant’s size per PRIME Study docs (NCT06429735). Roughly the size of a large coin. Sits flush with the skull. No external bump, no antenna, nothing you’d see or feel from the outside.
Here’s something people consistently get backward — the hermetic seal on this thing protects the electronics from the body, not the other way around. Cerebrospinal fluid, ion gradients, enzymatic activity — all corrosive to unprotected silicon over time. The enclosure resists those conditions and keeps the chip alive in an environment that would eat unshielded electronics fast.
Power? Small internal battery. Charged wirelessly through the scalp via inductive charger. No cables, no skin breach. (Honestly, that part is elegant. One of the cleaner design choices in the whole system.)
The 1,024 Electrodes: Here’s Where It Gets Real
I’ve noticed that coverage of this technology tends to skim the electrode architecture and move straight to the “paralyzed man controls computer” headline. Understandable. But you miss the whole engineering story if you do that.
The N1 carries 1,024 total electrodes, per the PRIME Study brochure. Thread config has evolved — Arbaugh’s original January 2024 implant used 64 threads, 16 electrodes each. Multiple outlets, including TechTimes (May 2026), RobotCentral (January 2026), and Neurapod, all report later patients got 128 thinner threads with 8 electrodes each, same 1,024 total. No peer-reviewed spec for that change yet, but it lines up across multiple sources and directly addresses the mechanical problem that caused Arbaugh’s thread retraction.
For scale: deep brain stimulation devices for Parkinson’s — a different device class built for stimulation, not recording — typically run around 10 electrodes. Neuralink’s recording array is substantially more. That said, I know what you’re thinking — channel count isn’t the whole story. You’re right. Electrode geometry, impedance, and placement depth all affect actual signal quality independently. Channel count is the headline. Signal quality is the actual measure.
Why does count matter then? It’s pure sampling math. More electrodes, more neurons sampled at once. More neurons, richer signal. Richer signal, better decode of intent. At the end of the day, 1,024 is enough to capture the motor cortex’s population-level activity so that one thread dropping out doesn’t collapse the whole read.
The N1’s design target, per Neuralink’s 2019 white paper (Musk & Neuralink, J Med Internet Res, PMC6914248), is placing electrodes within 60 microns of target neurons — not a hard universal law, but the specific proximity goal for this system, at which reliable action potential detection works. Miss it, and the signal drowns.
The N1 SoC: The Part Everyone Skips (And It Drives Me Crazy)
The chip itself is Neuralink’s N1 System-on-Chip (SoC). In my experience, this is the component that gets maybe one paragraph in mainstream coverage — if that. And honestly? I was going to skip a full section on it myself when I first started putting this together, because I figured readers would glaze over. Then I looked at the actual numbers from the primary source and changed my mind immediately.
If you only read one section of this piece, make it this one. The electrode count is the flashy part. The SoC is where the actual engineering lives, and the fact that nobody talks about it is just — look, it’s a pet peeve. I’ve sat through too many tech briefings where the chip architecture gets one slide, and the product renders get fifteen.
The SoC takes raw analog neural signals, amplifies them, digitizes them, and processes them before anything goes over the air. That step is not optional. Raw broadband neural data is enormous. Push it all wirelessly, and you kill the battery in minutes and flood the link.
Look, I know quoting directly from a white paper sounds incredibly dry, but bear with me — these are verbatim numbers from the 2019 primary source (DOI: 10.2196/16194, PMC6914248) and they’re worth reading slowly: “The on-chip ADC samples at 19.3 kHz with 10-bit resolution. Each analog pixel consumes 5.2 µW, and the whole ASIC consumes approximately 6 mW, including the clock drivers.”
Take a second with that.
19.3 kHz is 19,300 voltage reads per second per channel. Across every active electrode at once. That’s a flood of raw data — far too much to push wirelessly without wrecking the power budget. So the chip runs an on-chip spike detection algorithm first.
Per Neuralink’s 2019 launch event (engineer DJ Seo’s presentation — company-stated, not peer-reviewed, so keep that in mind), the algorithm hits more than 200× data compression in around 900 nanoseconds. On the other hand, maybe I’m too quick to take those exact figures at face value since they haven’t been independently verified in the peer-reviewed literature. Fair caveat.
But here’s the thing — the magnitude has to be roughly in that range. The physics doesn’t work any other way. You cannot run a wireless intracranial implant on a real battery while streaming uncompressed broadband neural data. The compression isn’t a feature. It’s what makes the device physically possible.
The ~6 mW total ASIC power is the other constraint that doesn’t get enough air time. Everything — amplification, digitization, spike detection, compression, bidirectional stimulation — sealed inside an enclosure charged through the scalp, inside a skull. Thermal limits in the intracranial space are fractions of a degree Celsius. That power ceiling isn’t a design target. It’s a hard patient safety line.
One more thing worth stating: the N1’s nominal electrode count is 1,024. The functional count — electrodes actually recording useably — is lower and degrades over time as glial scarring kicks in and threads retract. Arbaugh lost roughly 85% of recording threads in three months. Nominal versus functional electrode count is not a minor asterisk. It’s central to any real read of performance.
The R1 Robot: This Cannot Be Done by Hand
Jump straight to the constraint: thread diameters of 4 to 6 µm, per the 2019 white paper (PMC6914248). That’s 1/10th to 1/25th the width of a human hair. You cannot insert these manually at the speed, repeatability, and real-time vascular avoidance the procedure needs. Not difficult. Not inadvisable. Not possible at scale.
The R1 Robot uses a five-axis system with an ultrafine needle — thinner than a hair — to grasp, insert, and release each electrode thread under real-time imaging. Per Engineering and Technology Magazine (May 2026), it steers around blood vessels live during insertion using imaging feedback. Nick a vessel and you get bleeding, inflammation, signal loss. Not acceptable.
In my experience working in high-tolerance manufacturing, the first instinct is to benchmark this against PCB fab tolerances — sub-50 µm HDI work, laser microvias, that world. And I get why. I’ve covered HDI manufacturing tolerances in more depth on Silicon to Software — the comparison here is intentionally high-level.
But I think that comparison undersells what’s actually hard here. PCB fabrication runs in controlled, rigid, stable material where you set every parameter. The R1 works in living tissue that pulses with every heartbeat, varies in stiffness between patients and regions, and has vasculature you cannot touch.
The tolerance number is similar. The environment is incomparable. Biological variance is the real engineering challenge — the tolerance is just the minimum bar to clear.
The procedure: craniotomy, general anesthesia, R1 handles the thread insertion phase under neurosurgeon supervision. Multiple threads per minute. Motor cortex targeting, per the PRIME Study brochure — the region that controls movement intent. That’s the source of Arbaugh’s cursor signals.
The Problem Nobody Has Cracked
There is a biological response to every foreign object placed in a brain. Every single one. Doesn’t matter how thin the threads are, how biocompatible the coating is, or how careful the robot is. The brain’s immune system wakes up.
Reactive astrocytes and microglia — the brain’s cleanup cells — detect the threads and start wrapping the electrode tips. That wrapping raises impedance at the electrode-tissue contact point and kills signal quality over time. This is glial scarring.
It is the central unsolved long-term problem for every implantable BCI — not just Neuralink’s. Polikov, Tresco, and Reichert mapped the full cellular cascade in their foundational 2005 Journal of Neuroscience Methods paper. The field has been engineering around it since. Nobody has solved it.
Now, here’s where it gets weird — and also kind of impressive, depending on how you look at it.
Back to Arbaugh: roughly 85% thread retraction in three months. Neuralink patched it with a smarter decode algorithm — credit where it’s due, the cursor kept working — but the fix was software. The hardware had degraded, and the whole situation is just a total mess to deal with from a long-term reliability standpoint, even if the short-term outcome was fine.
I think that’s worth sitting with. On the other hand, a system that takes a significant hardware hit and still functions through adaptive software is arguably a better real-world outcome than something brittle that fails hard when one thread goes down. I genuinely go back and forth on how to frame it, and I’ve rewritten that sentence about four times while putting this together.
Thinner threads reduce the mechanical disruption that starts the glial cascade. Less stiffness, less tissue damage, less immune response. Helps. Doesn’t fix it. Nothing does yet.
Wireless Transmission and the Security Gap
Once the SoC compresses the data, it fires wirelessly to an external receiver, which feeds the N1 User App, which decodes patterns into commands — cursor movement, scrolling, clicks. For future CONVOY trial participants (robotic arm feasibility study, approved mid-2025), it’ll mean controlling a physical arm.
By the way — this next section is the one I debated cutting entirely because I wasn’t sure it belonged in a hardware explainer. Then I remembered that the whole point of writing about hardware is to be honest about what we don’t know, not just what we do.
Here’s the thing I want to flag directly for any engineer reading this, because it’s not getting enough coverage.
As of June 2026, Neuralink has published nothing on the N1’s wireless security architecture. No SBOM. No threat model. No disclosed encryption or auth protocol.
Under Section 524B of the FD&C Act and FDA’s updated cybersecurity guidance (revised February 2026), every “cyber device” going through premarket approval now needs a Software Bill of Materials, a Secure Product Development Framework, and documented threat modeling. The PRIME Study runs under an Investigational Device Exemption rather than a full PMA — different bar — but the regulatory direction is clear. An undocumented wireless implant is a submission risk, not just a theory.
Fair enough, but I want to be careful here — absence of public documentation doesn’t mean the work hasn’t been done internally. Halperin et al. (2008, IEEE Symposium on Security and Privacy) showed real exploitable gaps in cardiac implantable devices before the field took this seriously. That paper is 18 years old.
Don’t sweat the 2008 date — the point is that wireless implant security is an established engineering discipline with documented precedent, and the public record for the N1 has none of it. Absence of public documentation is not evidence of either a problem or safety — it’s just an absence.
Where Things Stand Right Now
Multiple outlets have reported additional PRIME Study participants across US, UK, Canada, and UAE. Neuralink’s own public materials say “multiple participants” — no count, no peer-reviewed update. Media “20+” figures are out there but unverified at the primary source level. Don’t sweat the exact number — what matters is the trial is running and expanding geographically.
May 2026: Neuralink announced the next-gen robot is aimed at brain regions beyond the motor cortex. Parkinson’s, refractory epilepsy, treatment-resistant depression all named as future targets. No published spec on scope yet.
The roadmap beyond that — Neuralink’s 2019 vision described a four-chip architecture, potentially thousands of electrode channels working together. Not confirmed for human deployment. Timeline not available.
The gap between the 2019 prototype (3,072 electrodes, 12 ASICs, 96 threads) and the deployed N1 (1,024 electrodes, one chip) is the gap between what you can demo and what you can actually make reliable enough to put in a person. That gap is the engineering project. It’s a toss-up whether the prototype ambition or the shipped hardware tells you more about where this field really is — I’d argue the shipped hardware every time.
What This Hardware Actually Proves
Noland Arbaugh moved a cursor.
Simple sentence. Not simple hardware. What Neuralink showed — and what the specs back up — is that you can put over a thousand electrodes in a living human brain, sample neural signals at 19.3 kHz, compress that data more than 200-fold on-chip in under a microsecond, and send it wirelessly to an app that turns thought into action.
I was looking back over this data earlier while writing this section, and it hit me that what makes the Arbaugh moment remarkable isn’t any single spec — it’s that all of them held at the same time.
The electrode placement was precise enough, the ASIC ran cool enough to stay within the thermal ceiling, the compression algorithm was fast enough that the wireless link didn’t choke, and somehow the decoding software was flexible enough to keep working even when 85% of the hardware reading the signal had already retracted.
That’s not one engineering win. That’s five or six of them stacking simultaneously, in a human skull, on the first real try.
Not science fiction. A clinical trial with a registration number.
The headlines chase the vision. Engineers — and honestly, anyone who actually wants to understand what’s happening — should follow the chip.
About the Author
Imran Valiani | Sales Director, PCB Electronics Manufacturing — 20+ years working with major Bay Area and global tech clients. Founder of Silicon to Software, where I write about the hardware layer — PCB fab, AI gear, autonomous systems, and cyber — the stuff most tech writers have never touched. Literally.
Follow: X @SiToSoftware | LinkedIn
This post was written with AI assistance. See my full AI disclosure.
Sources
- Musk, E. & Neuralink — “An Integrated Brain-Machine Interface Platform With Thousands of Channels.” Journal of Medical Internet Research, October 2019. DOI: 10.2196/16194. PubMed Central: PMC6914248
- Neuralink PRIME Study Brochure — Precise Robotically IMplanted Brain-Computer InterfacE. Clinical trial registration: NCT06429735. neuralink.com/pdfs/PRIME-Study-Brochure.pdf
- ClinicalTrials.gov — PRIME Study registration, NCT06429735. clinicaltrials.gov/study/NCT06429735
- Polikov, V.S., Tresco, P.A. & Reichert, W.M. — “Response of brain tissue to chronically implanted neural electrodes.” Journal of Neuroscience Methods, 2005. Foundational peer-reviewed study on glial scarring in implantable BCI systems.
- Halperin, D. et al. — “Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses.” IEEE Symposium on Security and Privacy, 2008. Peer-reviewed precedent for wireless implantable device security vulnerabilities.
- U.S. Food and Drug Administration — Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions. Guidance document, updated February 2026. fda.gov/regulatory-information/search-fda-guidance-documents
- U.S. Food and Drug Administration — Section 524B, FD&C Act: Cybersecurity Requirements for Cyber Devices. FAQ and portal: fda.gov/medical-devices/digital-health-center-excellence/cybersecurity
- Engineering and Technology Magazine — Neuralink R1 surgical robot coverage, May 2026.
- TechTimes — Neuralink PRIME Study patient and hardware update reporting, May 2026.
- Fierce Biotech — Neuralink CONVOY robotic arm study approval, June 2025.
- Neuralink — Official technology and trial pages. neuralink.com/trials/device-control
